Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pagliuca

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|August 28, 1998
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 casesR Pawson, D S Richardson, A Pagliuca, et al.
Journal of Medical Virology|October 26, 2006
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumabS E Moses, Z Y Lim, M Sudhanva, et al.
Oncogene|November 7, 2012
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repressionA Pagliuca, C Valvo, E Fabrizi, et al.
The Quarterly Journal of Medicine|September 1, 1990
In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative stateA Pagliuca, G J Mufti, M Janossa-Tahernia, et al.
The New England Journal of Medicine|February 3, 2000
Correction of the hyper-IgM syndrome after liver and bone marrow transplantationN Hadzić, A Pagliuca, M Rela, et al.
Journal of Hepatology|February 7, 1998
The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipientsM McCarthy, J Ramage, A McNair, et al.
Leukemia Research|September 23, 2008
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantationZ Y Lim, G Cook, P R Johnson, et al.
Bone Marrow Transplantation|November 25, 2010
The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysisG Cook, G H Jackson, G J Morgan, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Bone Marrow Transplantation|February 27, 2007
Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantationL Gooneratne, Z Y Lim, A du Vivier, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|August 28, 1998
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 casesR Pawson, D S Richardson, A Pagliuca, et al.
Journal of Medical Virology|October 26, 2006
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumabS E Moses, Z Y Lim, M Sudhanva, et al.
Oncogene|November 7, 2012
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repressionA Pagliuca, C Valvo, E Fabrizi, et al.
The Quarterly Journal of Medicine|September 1, 1990
In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative stateA Pagliuca, G J Mufti, M Janossa-Tahernia, et al.
The New England Journal of Medicine|February 3, 2000
Correction of the hyper-IgM syndrome after liver and bone marrow transplantationN Hadzić, A Pagliuca, M Rela, et al.
Journal of Hepatology|February 7, 1998
The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipientsM McCarthy, J Ramage, A McNair, et al.
Leukemia Research|September 23, 2008
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantationZ Y Lim, G Cook, P R Johnson, et al.
Bone Marrow Transplantation|November 25, 2010
The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysisG Cook, G H Jackson, G J Morgan, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Bone Marrow Transplantation|February 27, 2007
Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantationL Gooneratne, Z Y Lim, A du Vivier, et al.
Pageof 12